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ScienceDirectNobody doubts that infections have imposed specialisations
on the mammalian genome. However sufficient information is
usually missing to attribute a specific genomic modification to
pressure from a specific pathogen. Recent studies on
mechanisms of mammalian resistance against the ubiquitous
protozoan parasite, Toxoplasma gondii, have shown that the
small rodents presumed to be largely responsible for
transmission of the parasite to its definitive host, the domestic
cat, possess distinctive recognition proteins, and interferon-
inducible effector proteins (IRG proteins) that limit the potential
virulence of the parasite. The phylogenetic association of the
recognition proteins, TLR11 and TLR12, with T. gondii
resistance is weak, but there is evidence for reciprocal
polymorphism between parasite virulence proteins and host
IRG proteins that strongly suggests current or recent
coevolution.
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Infection modifies genomes
The mammalian genome has clearly been influenced by
infection. The extraordinary genomic complexity of the
rearranging receptors of lymphocytes and the complex
array of immune functions assembled in the mammalian
MHC are testimony to millions of years of pathogen
pressure.
Less straightforward is to document where and how
specific pathogens have triggered specific genomic
effects. Recent fatal pandemics have left their marks
on the human genome, for example in the shape of awww.sciencedirect.com number of more or less dysgenic alleles of a-globin and
b-globin for malaria, witnessing the urgency and intensity
of selection by novel pathogens. In mice the superanti-
genic ORF proteins of endogenous mammary tumor
viruses appear to have taken a toll of T cell receptor
Vb families [1] as the selective priorities for the mouse
seem to have favoured a sub-optimal T cell repertoire
over the risk of inflammatory death.
The strongest evidence for a definite recent causal rela-
tionship between specific features of pathogen and host
genomes is reciprocal polymorphism with an experimen-
tally demonstrable causal chain. Apart from the classic
examples noted above, this level of analysis has only
occasionally been achieved, and most notably in plant
disease resistance [2]. When experimental data has
been substantiated by ecological evidence, one may fairly
describe such a scenario as co-evolution.
The evolutionarily significant host (ESH)
The pattern of host–pathogen co-evolution depends on
the extent to which host resistance reduces pathogen
transmission. Fast-evolving pathogens counter this cost
by rapid evasive evolution. These familiar ‘Red Queen’-
like processes can result in polymorphic variation in host
and pathogen as each attempts to sidestep the other.
Toxoplasma gondii (T. gondii) is an extremely promiscuous
pathogen, generating recombinational diversity through
gametogenesis in all species of true cats, and all warm-
blooded animals are potentially intermediate hosts (see
Figure 1). Evolutionary significance of hosts for T. gondii
is therefore not yes or no, but a quantitative parameter.
Some species are certainly in this sense important hosts
for transmission of the pathogen, others probably not, a
distinction applying equally to definitive and intermedi-
ate hosts. In a comparison between important and less
important hosts we might identify genomic signatures of
the immune resistance machinery that reflect selective
pressure from the parasite on the ESH.
The evolution of T. gondii will be driven in the fore-
seeable future by its relationship with the domestic cat
as definitive host, but the absolute dominance of the
domestic cat is recent and it is unknown whether any
genomic coadaptation has already occurred. The limit-
ed genotypic diversity of T. gondii in the Old World
compared with S. America may reflect an ancient S.
American origin for the species [3] although there are
arguments against this view [4]. In any case, the original
genetic diversity of Old World T. gondii may have beenCurrent Opinion in Microbiology 2016, 32:19–25
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The Toxoplasma gondii life cycle, highlighting the distinction between evolutionarily relevant hosts and irrelevant hosts. The infected domestic cat
excretes oocysts into the environment with the feces where they are inadvertently ingested by foraging animals. Humans may be infected via
contact with cat feces in the domestic environment and in other ways. After a brief proliferative phase (tachyzoite) immunity may develop and
restricts further growth. In this case the parasite undergoes a phase change to a slowly-replicating form (bradyzoite), building cysts in brain and
muscle that persist for the life of the intermediate host. If the intermediate host is in the food-chain of domestic cats, as common birds and small
mammals are, then it is relevant for transmission and of evolutionary relevance to the parasite. Infected hosts outside the food chain of the
domestic cat, like humans, are irrelevant for transmission. The parasite must stimulate an effective immunity shortly after infection to ensure
avirulence; failure to do so allows uncontrolled proliferation and the early death of the host. Virulence is clearly costly for the host and in mice and
probably other small rodents. The highly polymorphic IRG system of IFNg-inducible GTPases provides resistance against T. gondii strains of
difference virulence without achieving sterile immunity. Presumably the selective advantage of the high virulence for mice, seen in some strains of
T. gondii, reflects pressure on the parasite from other evolutionarily relevant hosts that can indeed achieve sterile immunity during primary
infection. So far, high virulence has always been attributed to the ROP5/ROP18 complex of virulence proteins, known to target IRG proteins (see
Figure 2), so it is likely IRG proteins are also required for the induction of sterile immunity in such hosts.larger and the recent expansion of the domestic cat, an
Old World species until the sixteenth century, may
have favoured a specific subset of pre-adapted geno-
types.
The identification of dominant ESH species as interme-
diate hosts is more complex, but mammal or bird species
that are rare or inaccessible as prey for domestic cats
must be low down on the hierarchy, while species that
are abundant and accessible are high up. Humans, on the
other hand, while abundant and globally infected by
T. gondii at a rate over 1% per year of age [5], are
inaccessible as prey for domestic cats and can be elimi-
nated as an ESH. The parasite is completely uninter-
ested in defeating, or being defeated by, human
immunity. In the event, while human immunity is
normally sufficient to reduce morbidity from T. gondii
infection to very low levels, the parasite’s exceptional
ability to use host immunity in general as a trigger for
bradyzoite conversion means that infected humans do
carry cysts and so far no immunity sufficient for parasite
elimination has yet been recorded in man. What we may
fairly say is that no components of human immunityCurrent Opinion in Microbiology 2016, 32:19–25 seem to be specifically dedicated to resistance against
T. gondii. The human genome thus seems to provide a
reasonably reliable negative control.
What about the strong ESH candidates? Cat and mouse
are global species and sympatric. Furthermore, foraging
mice should have a significant chance of ingesting oocysts
spread in cat feces. Infection rates in urban Mus musculus
above 50% have been reported in the UK [6], but much
lower rates (0–5%) are more general [7–10]. In US studies,
infection of wild M. musculus is reported to be in the low
range (0–3% [11,12]) and values for the US native mouse,
Peromyscus, are similar [13]. Since unconfined domestic
cats defecate and hunt in the natural environment adja-
cent to their homes, rather than at home, the ecology of
Apodemus and other local wild-life may be more relevant
to the evolution of modern T. gondii in Europe than that of
M. musculus. Significant infection rates have been
reported in the European field mouse, Apodemus
[14,15] as well as in voles and shrews [8,16], abundant
Eurasian small mammals often found near human habi-
tation but scarcely overlapping in range with the domestic
mouse. Likewise, domestic cats regrettably catch thewww.sciencedirect.com
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unloved but abundant urban feral rock pigeons. These
may also be important ESH species, but it is certain that a
significant proportion of T. gondii pass through M. musculus
during the generational cycle and the mouse is certainly
the best-known candidate for a species with significant
ESH credentials.
Immune mechanisms against Toxoplasma in
mice and humans
Two striking differences between mouse and man have
been highlighted, a recognition mechanism and an effec-
tor mechanism. In mice, innate recognition of T. gondii
infection depends on two members of the TLR (Toll-like
receptor) family, TLR11 and TLR12, probably forming a
heterodimer [17], and the trigger was identified as
T. gondii-profilin [18]. Both TLR proteins are absent in
human [18,19]. Without them, mice are susceptible to
normally avirulent T. gondii strains. Secondly, members of
a family of 10–20 interferon-g-inducible GTPases, the
IRG proteins [20], assemble on and disrupt the parasito-
phorous vacuole membrane [21]. IRG proteins are essen-
tial for mouse survival from normally avirulent T. gondii
infection [22,23]. Humans express only one non-induc-
ible IRG fragment, IRGM, of uncertain function. A
further family of interferon-inducible GTPases, the
65 kDa guanylate binding proteins (GBP), is present in
both species. In the mouse GBPs assemble on a propor-
tion of IRG-loaded parasitophorous vacuoles [24] and
contribute to the strength of IFNg-inducible resistance
[25–27]. In the human, GBPs do not assemble on para-
sitophorous vacuoles although a resistance function dis-
tant from the vacuole has been proposed [28].
Much of the immune machinery involved in resistance
against T. gondii is, however, common to man and mouse,
forming the general innate-adaptive response axis: macro-
phages, dendritic cells, IL-12, IFNg, CD4 and CD8
T cells, CD40, the MHC, as well as NO and active
oxygen radicals are all implicated in resistance against
T. gondii [29,30]. It was shown recently that polyubiquitin
is deposited on the vacuolar membrane in both mouse and
human cells [31,32,33]. Human resistance against
T. gondii is remarkably effective despite the absence of
TLR11/12 and IRG proteins. Tryptophan depletion by
the catabolic action of an IFNg-inducible indoleamine
dioxygenase has been implicated in restricting T. gondii
growth in human cells [34], but this has not been gener-
alizable over cell types and culture conditions [35]. The
human NLRP1 inflammasome has also been implicated
as an initiator of some cell-autonomous immunity in
human macrophages in the absence of IFNg [36], but
the effector mechanism is unknown. Human TLR5 has
recently been shown to be triggered by T. gondii-profilin
[37], arguably replacing TLR11/12. Perhaps immunity of
humans against T. gondii is the sum of small effects.
Certainly the human mechanism in its entirety doeswww.sciencedirect.com not exist in mice since loss of IRG or TLR11/12 proteins
is fatal. Thus we have a clear dichotomy: mice have
the essential TLR11/12 and IRG mechanisms but not
the human mechanisms, while humans have their mech-
anisms, whatever they may be, but not the TLR11/12 and
IRG mechanism.
What do these differences mean?
The known specializations of the mouse accompany its
ESH status [38,39]. It was further recently found that
IL-12 production in mice is triggered by live parasite
invasion, in human by phagocytosis [40] and the authors
state: ‘possibly reflecting a direct involvement of rodents
and not humans in the parasite life cycle.’ However while
mouse is an ESH and human not, no causal connection
has been offered. Gazzinelli and colleagues [39] tried to
strengthen the link, both for TLR11/12 and for IRG
proteins, by looking at a wider range of species, but no
convincing correlation emerged. IRG genes were certain-
ly most abundant in small rodents, but nearly absent in
rabbits. Horses, an unlikely prey for small cats, have no
recorded IRG genes but their relative abundance in
elephants and manatees stretches the correlative argu-
ment too thin. The same problem afflicts the TLR11/12
distribution, present in rodents and lagomorphs, but also
in horses, rhinos, elephants and manatees. Absent or
pseudogenised in humans, orcas, dogs and cats, the ex-
pression of TLR11/12 seems to associate inversely with
carnivory, but this correlation too is destroyed by their
absence also from the obligate herbivore, the giant panda.
Reciprocal polymorphism strengthens the
argument
The correlative argument contains no causal link. If,
however, host and pathogen show reciprocal polymor-
phism in virulence and resistance, it would suggest that
the system is under selection. In the TLR11/12 recogni-
tion/response mechanism against T. gondii-profilin, no
relevant polymorphism was found correlating with infec-
tion status in Apodemus [41]. However in the IRG system
in mice, there is functional reciprocal polymorphism with
T. gondii virulence proteins [42]. Eurasian T. gondii strains
designated type I are virulent for laboratory mice, for
example, C57BL/6. Differential virulence of T. gondii
strains is due to allelic variation in two homologous,
polymorphic secreted proteins, a kinase (ROP18) and a
pseudokinase (ROP5). Together, these phosphorylate
two conserved threonines on effector IRG proteins and
inactivate them [43]. Type I strains are, however, resisted
by a wild-derived mouse strain, CIM, from South India
[42]. In crosses between CIM and C57BL/6, all the resis-
tance maps to a highly polymorphic IRG gene cluster on
chromosome 11. The polymorphic surface of the pseudo-
kinase ROP5 binds the nucleotide-binding domain of
Irga6 adjacent to the target threonines [42,44]. This sur-
face region, on the homologous Irgb2-b1 protein encoded
on chromosome 11, is the same region that shows evidenceCurrent Opinion in Microbiology 2016, 32:19–25
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Susceptibility and resistance of mouse genotypes against type I virulent strains of T. gondii. A typical laboratory inbred strain such as C57BL/6
(left panel) expresses effector IRG proteins such as Irga6 that are phosphorylated and inactivated by a kinase complex of ROP5 and ROP18
secreted by the parasite. Immunity against T. gondii fails and the mice die within a few days of infection. Such susceptible IRG alleles are
segregating in wild mouse populations with other IRG alleles that confer resistance to the virulent kinase complex (right panel). In particular, the
highly polymorphic ‘tandem’ IRG protein, Irgb2-b1, of such resistant strains (e.g. CIM) acts as a decoy, diverting the active kinase complex from
effector IRG proteins and allowing adequate immunity to develop to control the tachyzoite growth phase. In a mouse with such a genotype,
‘virulent’ T. gondii strains become avirulent, form cysts, and can be transmitted. Other wild strains (such as DDO from Denmark and DEB from
Spain) carry susceptible b2b1 haplotypes [48] and will be as vulnerable as C57BL/6. We hypothesize that ROP kinases highly virulent for mice
arise under pressure from evolutionarily relevant intermediate hosts that express IRG proteins capable of yielding sterile immunity to a primary
infection. So far, sterile immunity is unknown in mice: we presently view the origin of the highly resistant Irgb2-b1 alleles of mice as a response to
pressure from highly virulent T. gondii strains.of recent directional selection. Irgb2-b1 from the CIM
mouse transfected into C57BL/6 cells blocks phosphory-
lation of Irga6 by a virulent type I strain of T. gondii.
In this analysis, the argument favouring a causal chain
from virulence to resistance is complete. The polymor-
phic variation of Irgb2-b1 ‘matches’ the polymorphic
variation of parasite ROP5 and the results have biological
meaning. Type I strains that are virulent in mice carrying
the laboratory mouse allele of Irgb2-b1 kill their host
within a few days and thereby essentially eliminate the
chance of their own transmission. In mice carrying the
CIM allele of Irgb2-b1, however, both parasite and host
profit; the parasite can encyst in a resistant host, while the
host lives out a normal life (Figure 2).
These results leave us with a number of questions. It has
recently been shown that much of the virulence of
S. American T. gondii strains for laboratory mice is alsoCurrent Opinion in Microbiology 2016, 32:19–25 due to alleles expressed at ROP5 [45]. Can we conclude
that the allelic variation in ROP5 across multiple parasite
strains globally is all directed at allelic variants of IRG
proteins? Or are different ROP5 alleles directed at en-
tirely different target proteins relevant to different ESH
species? The house mouse is a Eurasian species, yet most
of the polymorphic variation in ROP5 is found among the
enormous diversity of S. American strains [35]. Which
species are ESHs in S. America and what if any IRG
proteins do they have? Since the resistant allele of Irgb2-
b1 is advantageous to both host and parasite at least in
Eurasia, why is it not fixed? What selection pressure has
led to the evolution of the susceptible Irgb2-b1 allele of
the laboratory mouse strains and to its greatly reduced
expression level (unpublished results Lilue & Mu¨ller)?
Just as the polymorphic virulence factors of T. gondii may
have different molecular targets in different ESH species,
so the IRG resistance system is certainly not directedwww.sciencedirect.com
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system found among laboratory mouse strains also regu-
late resistance to Chlamydia trachomatis [46] and Chlamydia
psittaci [47], while IRG proteins are also essential for
resistance of mouse cells against the microsporidian fun-
gus, Encephalitozoon cuniculi, although differential resis-
tance has not been shown for IRG alleles [48]. Both
Chlamydiales and Microsporidia are ubiquitous and
abundant pathogen classes and may well be more impor-
tant for the evolutionary dynamics of the IRG system
than Toxoplasma.
The struggle for avirulence
The strategy of T. gondii as a parasite is based on a quest
for avirulence, a capacity to attenuate but not to destroy
the immune resistance of the host, thus securing the
permanent residence required to await transmission.
How the parasite achieves this ideal state in thousands
of potential hosts, with strikingly different immune sys-
tems is the major unknown in T. gondii biology. This
power is analogous to the ability of the adaptive immune
system of vertebrates to resist thousands of different
pathogens. The adaptive immune system shows little
co-adaptation at a genomic level to different pathogens;
it is a general anti-pathogen machine. Likewise, T. gondii
has a general anti-host machine, not perfect, but able to
titrate host immunities of many different kinds against
the self-destructive potential of its own replicative
powers. Armed with this instrument, whatever it consists
of, it is presumably irrelevant whether a specific host
species is an ESH or not. Polymorphic variation in ROP5
and ROP18 is essential in mice, that use the IRG system,
but irrelevant in humans, that do not [35]. Presumably the
polymorphism and regulation of other genetic systems are
essential against different immune resistance mecha-
nisms favoured by other host species. T. gondii sometimes
fails to achieve its goal of avirulence in geographically
incoherent infections; some strains of S. American
T. gondii are highly virulent in humans [49], a non-native
species, and many S. American strains are highly
virulent for laboratory mice, which represent W. Europe-
an M. m. domesticus >90% genetically [50]. Likewise, the
type I Eurasian strains relatively frequent in the far East
are highly virulent for laboratory mouse strains but aviru-
lent for M. m. castaneus strains from the East Asian region.
These instances hint at further co-evolution between
T. gondii and its intermediate hosts.
Conclusion
For the moment the proven relationship between poly-
morphic virulence alleles of T. gondii and the proven
resistance alleles of the IRG system of mice presents
the strongest evidence that this host pathogen-pair are
now or have recently been in a dynamic co-evolutionary
relationship of sufficient intensity to contribute to ge-
nome modification through allelic diversification by both
partners. The weak correlation in species distribution ofwww.sciencedirect.com the TLR11/12 pair possibly suggests that this recognition
system also helps or has recently helped several mammals
in immunity against T. gondii, but does not tell us that
selection by this organism has brought it into existence,
any more than that it is likely that H-2Ld, for example,
which is known to present several T. gondii peptides to
T cells [51,52] owes its existence to the parasite, and
there is no evidence yet in either case of a dynamic co-
evolutionary process at work.
T. gondii has evolved a complex orchestra of actions that
play on vertebrate pathogen resistance machinery and
except in the case of the IRG system there is little reason
to believe that host resistance machinery is anything
other than beneficial to both host and parasite in enabling
the avirulent state and encystment. The polymorphism of
Irgb2-b1 and its intimate association with the virulence
polymorphism of ROP5 and ROP18 raises the question,
what selection generates type I virulence in T. gondii
strains where M. musculus is an ESH? Avirulent types
II and III strains can also encyst in the highly resistant
CIM mice so there is no ‘need’ for extra virulence.
Arguably, the type I virulent strains are preferentially
adapted to another important ESH species, perhaps a rat,
whose IRG system is capable of enforcing sterile immu-
nity on strains lacking the virulent alleles of ROP5 and
ROP18. The Irgb2-b1 allele of mice would then be
accounted for as an essential adaptation for mice living
within the range of such virulent strains, perhaps typically
in the Far East. Polymorphic variation in the IRG system
is probably also driven by other parasites as well, for
example Chlamydia or Microsporidia. Allelic frequencies
will depend on the ratio of the intensity of selection
pressures from the parasites.
Much work will be required and at many different ana-
lytical levels, genetic, biochemical, structural, ecological
and immunological, to clarify these issues.
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